Page 5,752«..1020..5,7515,7525,7535,754..5,7605,770..»

3D Printing Advances Stem Cell Research

Posted: Published on February 6th, 2013

Scientists have taken a step closer to creating artificial human organs and using them for transplants after 3D printing produced clusters of stem cells. In the short term, the technique could be used to generate tissue for drug-testing currently carried out on animals. The 3D printing technology relies on an adjustable "microvalve", which builds up layers of human embryonic stem cells. Such cells, which originate from early stage embryos, are blankslates with the potential to become any type of tissue in the body. In the long term, the new printing technique could pave the way for those cells to be incorporated into transplant-ready laboratory-made organs and tissues, said researchers at Heriot-Watt University in Edinburgh The technique's breakthrough is in its gentle handling of the delicate cells which gives them a greater chance to thrive, they said. Lead scientist Dr Will Shu told Sky News: "We found that the valve-based printing is gentle enough to maintain high stem cell viability". He also said it was "accurate enough to produce spheroids of uniform size and, most importantly, the printed human embryo stem cells maintained their pluripotency - the ability to differentiate into any other cell type". Taking a cell from a patient … Continue reading

Posted in Stem Cell Research | Comments Off on 3D Printing Advances Stem Cell Research

YaFarm Technologies, Inc. Announces It Has Signed a Definitive Agreement With The Integrative Stem Cell Institute

Posted: Published on February 6th, 2013

PITTSTON, ME--(Marketwire - Feb 5, 2013) - YaFarm Technologies, Inc. ( PINKSHEETS : YFRM ) (YaFarm, or the Company) is pleased to announce that it has signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI). The ISCI is a pioneer in the field of cell-based regenerative medicine. Combining a world-class medical facility with a state-of-the-art laboratory, the ISCI provides investigational treatments to patients as part of clinical studies, while providing long-term follow up to advance these promising therapies. The acquisition of the ISCI provides the Company with an entry into stem cell research and treatment. With the advent of regenerative medicine, clinics such as the ISCI have taken the years of scientific research and started to apply them to treatment of patients. YaFarm Technologies President Brian Hermenze stated, "Since the 2012 Nobel Prize in Physiology or Medicine was awarded jointly to John B. Gurdon and Shinya Yamanaka for their work in stem cell research, we are very excited about the synergies this acquisition will bring to the Company. The ISCI has been providing point-of-care therapies to patients for over a year and operates at an internationally recognized medical facility accredited by both the Joint Commission and … Continue reading

Posted in Stem Cell Research | Comments Off on YaFarm Technologies, Inc. Announces It Has Signed a Definitive Agreement With The Integrative Stem Cell Institute

YaFarm Technologies, Inc. Announces a Definitive Agreement With The Integrative Stem Cell Institute

Posted: Published on February 6th, 2013

PITTSTON, ME--(Marketwire - Feb 5, 2013) - YaFarm Technologies, Inc. ( PINKSHEETS : YFRM ) (YaFarm, or the Company) is pleased to announce that it has signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI). The ISCI is a pioneer in the field of cell-based regenerative medicine. Combining a world-class medical facility with a state-of-the-art laboratory, the ISCI provides investigational treatments to patients as part of clinical studies, while providing long-term follow up to advance these promising therapies. The acquisition of the ISCI provides the Company with an entre into stem cell research and treatment. With the advent of regenerative medicine, clinics such as the ISCI have taken the years of scientific research and started to apply them to treatment of patients. YaFarm Technologies CEO Brian Hermenze stated, "Since the 2012 Nobel Prize in Physiology or Medicine was awarded jointly to John B. Gurdon and Shinya Yamanaka for their work in stem cell research, we are very excited about the synergies this acquisition will bring to the Company. The ISCI has been providing point-of-care therapies to patients for over a year and operates at an internationally recognized medical facility accredited by both the Joint Commission and … Continue reading

Posted in Stem Cell Research | Comments Off on YaFarm Technologies, Inc. Announces a Definitive Agreement With The Integrative Stem Cell Institute

Genetic patch cures deafness in newborn mice

Posted: Published on February 6th, 2013

London, Feb 5 (ANI): A tiny "genetic patch" can be used to prevent a form of deafness that runs in families, a new research has shown. Patients with Usher syndrome have defective sections of their genetic code which cause problems with hearing, sight and balance. A study showed the same defects could be corrected in mice to restore some hearing, the BBC reported. Experts said it was an "encouraging" start. There are many types of Usher syndrome tied to different errors in a patient's DNA - the blueprint for building every component of the body. One of those mutations runs in families descended from French settlers in North America. When they try to build a protein called hormonin, which is needed to form the tiny hairs in the ear that detect sound, they do not finish the job. It results in hearing loss at birth and has a similar effect in the eye where it causes a gradual loss of vision. Scientists at the Rosalind Franklin University of Medicine and Science, in Chicago in the US, designed a small strip of genetic material which attaches to the mutation and keeps the body's factories building the protein. There has been something … Continue reading

Comments Off on Genetic patch cures deafness in newborn mice

Lung cancer patients can benefit from genetic testing

Posted: Published on February 6th, 2013

VANCOUVER, Feb. 5, 2013 /CNW/ - Research shows the genetic make-up of a tumour can have a big impact on how a patient will respond to different treatment options. In the most common type of lung cancer, non-small cell lung cancer (NSCLC), clinical trials have shown that people whose tumours exhibit the epidermal growth factor receptor (EGFR) gene mutation often respond better to certain targeted therapies, which can lead to better outcomes. Approximately 10-20 per cent of all lung cancer cases have the EGFR gene mutation.i Research also indicates that 45 per cent of Asians with NSCLC have the EGFR gene mutation,ii making genetic mutation testing in lung cancer even more relevant in BC where 12 per cent of the population is of East Asian descent.iii East Asian, non-smoking women are at particular risk. One study showed 80 per cent of never-smoking Asian women with non-small cell lung cancer had EGFR gene mutations.iv The BC Cancer Agency is at the forefront of lung cancer genetic testing. EGFR testing is a standard of care that is offered at the BC Cancer Agency for patients that fit the criteria. Experts are gathering at the annual Canadian Lung Cancer Conference from February 7-8 … Continue reading

Comments Off on Lung cancer patients can benefit from genetic testing

Tiny Genetic Patch Stops Deafness

Posted: Published on February 6th, 2013

Editor's Choice Academic Journal Main Category: Hearing / Deafness Also Included In: Genetics Article Date: 05 Feb 2013 - 11:00 PST Current ratings for: Tiny Genetic Patch Stops Deafness 5 (1 votes) 4 (1 votes) The animal study, which is still in its early stages, could eventually develop into new treatments for Usher syndrome, a congenital hearing disorder which usually goes hand-in-hand with blindness as well. When the scientists injected the profoundly deaf mice with the genetic patch, they developed into partially hearing mice with no balance problems. The authors explained that deafness is the most common sensory disorder. Approximately 1 in every 1,000 newborns is born with a hearing impairment. Congenital deafness is often the result of the improper development or degeneration of cochlear hair cells which form the tiny hairs in the ear that detect sound. In one type of Usher syndrome - known as Type 1 Usher Syndrome - which French settlers brought to the USA hundreds of years ago, there is a problem with a protein called harmonin. Harmonin is required in order to form the cochlear hair cells. The same problem also causes gradual loss of vision. In type 1 Usher syndrome, there is a … Continue reading

Comments Off on Tiny Genetic Patch Stops Deafness

Kangaroo receives stem cell therapy treatment. – Video

Posted: Published on February 6th, 2013

Kangaroo receives stem cell therapy treatment. Emerald is a resident of Rolling Hills Wildlife Adventure. In a two-hour procedure Wednesday morning at the zoo's veterinary clinic she made kangaroo history by undergoing stem cell treatment on an injured left leg, something that's believed never to have been attempted on such an animal. Video by Devin Frederking By: Salina Journal … Continue reading

Comments Off on Kangaroo receives stem cell therapy treatment. – Video

Health Forum on Flu Vaccines and stem Cell treatment – Video

Posted: Published on February 6th, 2013

Health Forum on Flu Vaccines and stem Cell treatment I created this video with the YouTube Video Editor (www.youtube.com By: Mary Jane Olvina … Continue reading

Comments Off on Health Forum on Flu Vaccines and stem Cell treatment – Video

IELLIOS Ion Magnum Genius – Video

Posted: Published on February 6th, 2013

IELLIOS Ion Magnum Genius Dr Xanya Sofra Weiss gave an impressive lecture on the advantages of Signaling Technology when used with stem cell therapies By: Xanya Weiss … Continue reading

Comments Off on IELLIOS Ion Magnum Genius – Video

Stem Cell Treatment for Duchenne Muscular Dystrophy – Video

Posted: Published on February 6th, 2013

Stem Cell Treatment for Duchenne Muscular Dystrophy He is a known case of DMD since 1 year of age with history of falling while walking. Gradually, he has developed weakness in lower limbs and difficulty in getting up from the floor. Since 1 year he has difficulty in overhead activities. Neurologically, he is hypotonic and hyporeflexic. On examination, he has all sensations intact. He has grade 2++ muscle power in proximal muscles of lower limbs and grade 3 muscle power in upper limbs. He has bilateral calf muscle hypertrophy. Functionally, he requires minimal to moderate assistance in his ADL. He walks with a waddling gait. On FIM he scores 94. On Brooke scale he scores 8 and on Vignos scale he scores 16. Stem Cell Therapy done at NeuroGen Brain and Spine Institute Surana Sethia Hospital Sion-Trombay Rd, Suman Ngr Opp Corporate Park, Chembur, Mumbai -- 71. Tel : 022 - 25283706, 022 - 25281610, Mob : +91 9920 200 400 http://www.neurogen.in http://www.stemcellsmumbai.com By: neurogenbsi … Continue reading

Comments Off on Stem Cell Treatment for Duchenne Muscular Dystrophy – Video

Page 5,752«..1020..5,7515,7525,7535,754..5,7605,770..»